etoposide has been researched along with Ganglioneuroblastoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karangelis, D; Nikolaidis, N; Roubelakis, A; Weeden, DF | 1 |
| Brisse, HJ; Canale, S; Elie, C; Galmiche-Rolland, L; Irtan, S; Le Cossec, C; Michon, J; Minard-Colin, V; Sarnacki, S; Schleiermacher, G; Valteau-Couanet, D | 1 |
| Brons, P; Flucke, U; Salet, MC; Schreuder, B; Vogels, R | 1 |
| Azuhata, T; Griffith, TS; Miller, M; Sandler, AD; Scott, D | 1 |
| Boscherini, B; Ingrosso, A; Picone, S; Schiavetti, A | 1 |
| Aoki, I; Misugi, K; Miyagi, Y; Miyashita, M; Nagashima, Y; Nakatani, Y; Shigematsu, S; Tanaka, Y | 1 |
6 other study(ies) available for etoposide and Ganglioneuroblastoma
| Article | Year |
|---|---|
Giant thoracoabdominal ganglioneuroblastoma in a 17-year-old patient.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carboplatin; Disease Progression; Etoposide; Fatal Outcome; Ganglioneuroblastoma; Humans; Kidney; Laparotomy; Male; Mediastinal Neoplasms; Neoplasm, Residual; Thoracotomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Diagnostic Imaging; Etoposide; Female; Ganglioneuroblastoma; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Postoperative Complications; Risk Assessment; Risk Factors; Thoracic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2015 |
Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calmodulin-Binding Proteins; Cell Differentiation; Chemotherapy, Adjuvant; Child; Doxorubicin; Etoposide; Femoral Neoplasms; Femur; Ganglioneuroblastoma; Gene Rearrangement; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Oncogene Proteins, Fusion; Prognosis; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2016 |
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Child; Etoposide; Ganglioneuroblastoma; Ganglioneuroma; GPI-Linked Proteins; Humans; Inhibitor of Apoptosis Proteins; Membrane Glycoproteins; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasm Recurrence, Local; Neuroblastoma; Predictive Value of Tests; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; Survivin; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 2006 |
Growth hormone deficiency after localized ganglioneuroblastoma: A case report.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Body Height; Carboplatin; Etoposide; Ganglioneuroblastoma; Growth Hormone; Humans; Hypothalamus; Infant; Male; Pituitary Gland | 2006 |
Adult ganglioneuroblastoma of the anterior mediastinum.
Topics: Aged; Biomarkers, Tumor; Cell Differentiation; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Ganglioneuroblastoma; Humans; Immunohistochemistry; Male; Mediastinal Neoplasms; Melanocytes | 1997 |